Literature DB >> 965486

The origin of the chemiluminescence of phagocytosing granulocytes.

B D Cheson, R L Christensen, R Sperling, B E Kohler, B M Babior.   

Abstract

Granulocytes engaged in the phagocytosis of opsonized zymosan emit light by a process that is inhibited by superoxide dismutase and catalase. In the present report is is shown that light emission is the result of reactions between certain unspecified constituents of the ingested particles and some or all of the oxidizing agents (H2O2, O2),and possibly the hydroxyl radical and singlet oxygen) produced by the activated cells. This conclusion is based on a study of light emission by both activated cells ans artificial O2 generating system containing xanthine oxidase and purine. With these two systems light production required the presence of both zymosan and oxidizing agent, suggesting that the oxidation of particle components is necessary for luminescence to occur. The characteristics of the emission spectrum as well as the finding that granulocytes activated by a nonparticulate agent (F-) fail to liminesce show that light emission by the relaxation of singlet oxygen to the ground state does not contribute in a major way to the chemiluminescence of phagocytosing granulocytes; whether singlet oxygen contributes to chemiluminescence in other ways cannot be decided from the data available. Inasmuch as the oxidation of constituents of ingested particles is an important bacterial killing mechanism in the granulocyte, chemiluminescence may be viewed as a manifestation of the microbicidal activity of the cell.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965486      PMCID: PMC333240          DOI: 10.1172/JCI108530

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Microbe ingestion and killing by neutrophils: normal mechanisms and abnormalities.

Authors:  R L Baehner
Journal:  Clin Haematol       Date:  1975-10

2.  Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.

Authors:  S J Klebanoff
Journal:  Semin Hematol       Date:  1975-04       Impact factor: 3.851

3.  Defective superoxide production by granulocytes from patients with chronic granulomatous disease.

Authors:  J T Curnutte; D M Whitten; B M Babior
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

4.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

Review 5.  Superoxide dismutases.

Authors:  I Fridovich
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

Review 6.  Chronic granulomatous disease--pieces of a cellular and molecular puzzle.

Authors:  M L Karnovsky
Journal:  Fed Proc       Date:  1973-04

7.  The superoxide anion and singlet molecular oxygen: their role in the microbicidal activity of the polymorphonuclear leukocyte.

Authors:  R C Allen; S J Yevich; R W Orth; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

8.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Reduction and inactivation of superoxide dismutase by hydrogen peroxide.

Authors:  R C Bray; S A Cockle; E M Fielden; P B Roberts; G Rotilio; L Calabrese
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

10.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

View more
  68 in total

1.  A perspective on the oxidative burst in the phagosome of the leukocyte and its neoplastic transformation.

Authors:  Robert Sala Parcerisas
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

2.  Reassessment of the role of splenic leukocyte oxidative activity and macrophage activation in expression of immunity to malaria.

Authors:  L A Cavacini; M Guidotti; L A Parke; J Melancon-Kaplan; W P Weidanz
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

4.  Chemiluminescence in Wounded Root Tissue : EVIDENCE FOR PEROXIDASE INVOLVEMENT.

Authors:  M L Salin; S M Bridges
Journal:  Plant Physiol       Date:  1981-01       Impact factor: 8.340

5.  Chemiluminescence spectra of human myeloperoxidase and polymorphonuclear leukocytes.

Authors:  B R Andersen; A M Brendzel; T F Lint
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

6.  Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity.

Authors:  B Gudbjörnsson; N Feltelius; R Hällgren; P Venge
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

7.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

8.  Evidence for hydroxyl radical production by human neutrophils.

Authors:  A I Tauber; B M Babior
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.